The Valley Desk

Clinical trial reportCancer discoveryPublished

Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, with University of Pennsylvania linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Cancer discovery
Published
Subject terms
Humans; Neoplasm Recurrence, Local; Pyridones; Pyrimidinones; Protein Kinase Inhibitors; Treatment Outcome; Hematopoietic Stem Cell Transplantation; Drug Resistance, Neoplasm; Child; Child, Preschool; Infant; Female
PubMed ID
38867349
PubMed Central ID
PMC11374478
Added to directory
Source checked

Report a correction or request removal